The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives

Science Communicator Platform

Share By

The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives Publisher Pubmed

Ashrafizadeh M¹ ; Farhood B² ; Eleojo Musa A³ ; Taeb S⁴ ; Najafi M⁵

Source: International Immunopharmacology Published:2020

Abstract

Tumor microenvironment (TME) includes a wide range of cell types including cancer cells, cells which are involved in stromal structure and immune cells (tumor suppressor and tumor promoting cells). These cells have several interactions with each other that are mainly regulated via the release of intercellular mediators. Radiotherapy can modulate these interactions via shifting secretions into inflammatory or anti-inflammatory responses. Radiotherapy also can trigger resistance of cancer (stem) cells via activation of stromal cells. The main mechanisms of tumor resistance to radiotherapy is the exhaustion of anti-tumor immunity via suppression of CD4+ T cells and apoptosis of cytotoxic CD8+ T lymphocytes (CTLs). Cancer-associated fibroblasts (CAFs), mesenchymal-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) are the main suppressor of anti-tumor immunity via the release of several chemokines, cytokines and immune suppressors. In this review, we explain the main cellular and molecular interactions and secretions in TME following radiotherapy. Furthermore, the main signaling pathways and intercellular connections that can be targeted to improve therapeutic efficiency of radiotherapy will be discussed. © 2020 Elsevier B.V.

Related Docs

View other Related Docs

1. Damage-Associated Molecular Patterns in Tumor Radiotherapy, International Immunopharmacology (2020)

2. Targets for Improving Tumor Response to Radiotherapy, International Immunopharmacology (2019)

3. Tgf-Β in Radiotherapy: Mechanisms of Tumor Resistance and Normal Tissues Injury, Pharmacological Research (2020)

Experts (# of related papers)

View all Related Experts

Elahe Motevaseli (4)

Ghazaleh Geraily (1)

Other Related Docs

4. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy, Current Cancer Drug Targets (2022)

5. Abscopal Effect in Radioimmunotherapy, International Immunopharmacology (2020)

6. Radiation and Immunity: Hand in Hand From Tumorigenesis to Therapeutic Targets, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)

7. Mechanisms of Inflammatory Responses to Radiation and Normal Tissues Toxicity: Clinical Implications, International Journal of Radiation Biology (2018)

8. Cancer-Associated Fibroblasts (Cafs) and Tumor-Associated Macrophages (Tams); Where Do They Stand in Tumorigenesis and How They Can Change the Face of Cancer Therapy?, European Journal of Pharmacology (2022)

9. Tumor Microenvironment: Interactions and Therapy, Journal of Cellular Physiology (2019)

10. Cox-2 in Radiotherapy: A Potential Target for Radioprotection and Radiosensitization, Current Molecular Pharmacology (2018)

11. Mitochondria and Radioresistance, Mitochondria and Cancer: From Basic Science to Clinical Applications - Understanding Pathogenesis, Therapy Resistance, and Disease Relapse (2026)

12. Targeting of Inflammation for Radiation Protection and Mitigation, Current Molecular Pharmacology (2018)

13. The Paradox Role of Caspase Cascade in Ionizing Radiation Therapy, Journal of Biomedical Science (2016)

14. Contribution of Tumor Microenvironment (Tme) to Tumor Apoptosis, Angiogenesis, Metastasis, and Drug Resistance, Medical Oncology (2025)

15. Immunotherapeutic Targets in Non-Small Cell Lung Cancer, Immunology (2023)

16. Concomitant Blockade of A2ar and Ctla-4 by Sirna-Loaded Polyethylene Glycol-Chitosan-Alginate Nanoparticles Synergistically Enhances Antitumor T-Cell Responses, Journal of Cellular Physiology (2020)

17. Cancer-Associated Mesenchymal Stem/Stromal Cells: Role in Progression and Potential Targets for Therapeutic Approaches, Frontiers in Immunology (2023)

18. Melatonin As an Adjuvant in Radiotherapy for Radioprotection and Radiosensitization, Clinical and Translational Oncology (2019)

19. Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model, International Immunopharmacology (2022)

20. Modulation of the Immune System by Melatonin; Implications for Cancer Therapy, International Immunopharmacology (2022)

Style	Citing Format
MLA	Ashrafizadeh M, et al.. "The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives." International Immunopharmacology, vol. 87, no. , 2020, pp. -.
APA	Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M (2020). The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives. International Immunopharmacology, 87(), -.
Chicago	Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. "The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives." International Immunopharmacology 87, no. (2020): -.
Harvard	Ashrafizadeh M et al. (2020) 'The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives', International Immunopharmacology, 87(), pp. -.
Vancouver	Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives. International Immunopharmacology. 2020;87():-.
BibTex	@article{ author = {Ashrafizadeh M and Farhood B and Eleojo Musa A and Taeb S and Najafi M}, title = {The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives}, journal = {International Immunopharmacology}, volume = {87}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Ashrafizadeh M AU - Farhood B AU - Eleojo Musa A AU - Taeb S AU - Najafi M TI - The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives JO - International Immunopharmacology VL - 87 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract